Throat News and Research

RSS

Differentiating between sneezing due to cold and allergies

One of the problems that parents may have during the springtime is deciphering whether their children's sneezing is due to a cold or allergies.

31 Mar 2012

Needle-free vaccine shows promise against RSV in children

Researchers at the University of Saskatchewan are closing in on a needle-free vaccine for respiratory syncytial virus (RSV), a major cause of respiratory illness in children under two years of age.

30 Mar 2012

Ozone can trigger severe violent breathing attacks in many people

Ozone, the prevalent gas found in air pollution, and mostly experienced from March to October, can trigger severe violent breathing attacks in many people, particularly children and seniors, says a lung expert from Ben Taub General Hospital in Houston.

30 Mar 2012

Vaccination for HPV reduces risk of renewed disease

The vaccination against human papillomavirus (HPV) reduces the risk of a renewed HPV-associated illness in patients who have already had diseases as a consequence of an HPV infection.

29 Mar 2012

Skeptical justices ask tough questions about the insurance mandate

In yesterday's oral arguments, the grilling aimed at the Obama administration's lawyer by the court's conservatives raised the prospect that the law's centerpiece could be overturned.

29 Mar 2012

MedImmune receives FDA approval for FluMist Quadrivalent vaccine

FluMist Quadrivalent, a vaccine to prevent seasonal influenza in people ages 2 years through 49 years, has been approved today by the U.S. Food and Drug Administration. FluMist Quadrivalent is the first influenza vaccine to contain four strains of the influenza virus, two influenza A strains and two influenza B strains.

27 Mar 2012

Valeant signs agreement to acquire Natur Produkt

Valeant Pharmaceuticals International, Inc. announced today that Valeant has signed an agreement to acquire Natur Produkt International, JSC, a specialty pharmaceutical company in Russia.

26 Mar 2012

Aternative pain medication without narcotics safe after sinus surgery

Patients who have undergone sinus surgery can safely take an alternative pain medication that does not cause the side effects of narcotics such as fentanyl and Vicodin, a Loyola University Health System study has found.

23 Mar 2012

First Edition: March 23, 2012

Today's health policy headlines are full of previews of next week's health law action at the Supreme Court.

23 Mar 2012

Common infections could become deadly with increase in antibiotic resistance, WHO's Chan says

As more bacteria become resistant to antibiotics, "common infections could become deadly, according to" WHO Director-General Margaret Chan, who spoke on Wednesday at a conference titled "Combating Antimicrobial Resistance: Time for Action" in Copenhagen, ABC News reports.

19 Mar 2012

Air emissions near natural gas drilling sites may contribute to health problems

In a new study, researchers from the Colorado School of Public Health have shown that air pollution caused by hydraulic fracturing or fracking may contribute to acute and chronic health problems for those living near natural gas drilling sites.

19 Mar 2012

Rapid increase in number of HPV-related oral cancers in the UK

The number of oral cancer cases diagnosed each year in the UK has risen above 6,000 for the first time, new figures from Cancer Research UK show today.

16 Mar 2012

Study examines how symptoms presented online influence people's reactions to medical conditions

Maybe you've had a reoccurring sore throat or frequent headaches. Perhaps the pain in your leg won't go away. In the past, you might have gone to a doctor's office to diagnose symptoms.

13 Mar 2012

Pfizer’s Prevnar 13 Phase 3 study for pneumococcal disease meets all study endpoints

Pfizer Inc. announced today that data from a Phase 3 study of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) met all study endpoints, showing immunogenicity and establishing a safety profile in children and adolescents aged 5 through 17 years.

12 Mar 2012

Sientra’s breast implant approved by the U.S. FDA

The implant, manufactured by Santa Barbara-based Sientra, can be used for breast tissue reconstruction for women of any age and for breast augmentation in women 22 or older. The approval resulted from three years of clinical studies on almost 1,800 patients. Tightening of the area around the implant, re-operation, implant removal, uneven appearance and infection were some of the complications experienced during the study. Sientra is required to continue studies on the implant's long-term safety, effectiveness and risks of rare diseases under the approval.

12 Mar 2012

Researchers identify specific gene linked with throat cancer

Researchers at King's College London and Hiroshima University, Japan, have identified a specific gene linked to throat cancer following a genetic study of a family with 10 members who have developed the condition.

8 Mar 2012

Snoring toddlers may develop behavioural problems later: Study

A new study shows that babies and toddlers who snore, gasp for breath, or breathe with their mouth open while sleeping may be at a greater risk of behavioural problems all the way through second grade.

5 Mar 2012

Merck announces success of pill against ragweed allergy

Merck & Co. announced Monday that their experimental allergy tablet reduced allergic reactions to ragweed and helped patients use less medication to treat their symptoms.

5 Mar 2012

Inovio's SynCon vaccine for HPV types 6 and 11 induces CD8+ T cells in mice

Inovio Pharmaceuticals, Inc. announced today that its SynCon therapeutic vaccine for human papillomavirus (HPV) types 6 and 11, which are associated with head & neck cancers and genital warts, among other conditions, induced strong antigen-specific CD8+ T cells in mice.

5 Mar 2012

Young children with SDB more likely to develop neurobehavioral problems

A study of more than 11,000 children followed for over six years has found that young children with sleep-disordered breathing are prone to developing behavioral difficulties such as hyperactivity and aggressiveness, as well as emotional symptoms and difficulty with peer relationships, according to researchers at Albert Einstein College of Medicine of Yeshiva University.

5 Mar 2012